Global Antacids Market Analysis, Trends and Opportunities -2019
Summary -
A new market
study, titled “Global Antacids Market Analysis,
Trends and Opportunities -2019” has been featured on WiseGuyReports.
Reasons to Purchase
• Gain a truly global perspective
with the most comprehensive report available on this market covering 50+
geographies.
• Create regional and country
strategies on the basis of local data and analysis.
• Identify growth segments for
investment.
• Outperform competitors using
forecast data and the drivers and trends shaping the market.
• Understand customers based on the
latest market research findings.
• Benchmark performance against key
competitors.
• Utilize the relationships between
key data sets for superior strategizing.
• Suitable for supporting your
internal and external presentations with reliable high quality data and
analysis
• Report will be updated with the
latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest
growing market for the antacids? How does the market relate to the overall
economy, demography and other similar markets? What forces will shape the market
going forward? The Antacids Market Global Report from The Business Research
Company answers all these questions and many more.
The report covers market
characteristics, size and growth, segmentation, regional and country
breakdowns, competitive landscape, market shares, trends and strategies for
this market.
• The Market Characteristics section
of the report defines and explains the market.
• The Market Size section gives the
market size ($b) covering both the historic growth of the market and
forecasting the future. Drivers and restraints looks at the external factors
supporting and controlling the growth of the market.
• Market Segmentations break down
market into sub markets.
• The Regional and Country section
gives an analysis of the market in each geography and the size of the market by
geography and compares their historic and forecast growth. It covers all the
regions, key developed countries and major emerging markets. It draws
comparisons with country populations and economies to understand the importance
of the market by country and how this is changing.
• Competitive Landscape gives a
description of the competitive nature of the market, market shares, and a
description of the leading companies. Key financial deals which have shaped the
market in recent years are identified.
• The Trends and Strategies section
highlights the likely future developments in the market and suggests approaches
companies can take to exploit this.
Scope
Markets Covered: 1) Drug Class:
Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By
Formulation Type: Tablet, Liquid, Powder, Others
Companies Mentioned: GlaxoSmithKline
plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC
Countries: Australia, Brazil, China,
France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Regions: Asia-Pacific, Western
Europe, Eastern Europe, North America, South America, Middle East, Africa
Time Series: Five years historic and
forecast.
Data Segmentations: country and
regional historic and forecast data, market share of competitors, market
segments.
Sourcing and Referencing: Data and
analysis throughout the report is sourced using end notes.
The antacids market consists of sales
of antacids which are used to neutralize stomach acid, and treat acid reflux,
heartburn and indigestion. It includes drug class such as proton pump
inhibitors, H2 antagonist, surgical simulators and acid neutralizers in the
form of either tablet, liquid or powder. Examples of antacids include Alka
Seltzer, Maalox, Mylanta, Rolaids, Tums and Pepto-Bismol.
The global antacids market was valued
at about $4.62 billion in 2018 and is expected to decline to $4.55 billion at a
CAGR of -0.4% through 2022.
North America was the largest region
in the antacids market in 2018. Asia Pacific and Latin America respectively.
Poor lifestyle choices resulting in
higher prevalence of acidity is an important driver for the growth of the
antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of
sleep and irregular dietary habits, which result in an increase in acidity
level of the stomach and lead to gastroesophageal reflux disease. According to
the American College of Gastroenterology, around 60 million Americans suffers
from gastroesophageal reflux disease. This drives the demand for antacids.
The side effects related to antacids
is a major restraint for the antacids market. Some of the common side effects
of antacids include dose-dependent rebound hyperacidity and milk-alkali
syndrome. Antacids containing aluminum hydroxide may also cause side effects
such as constipation, aluminum-intoxication, osteomalacia, and
hypophosphatemia. In addition, antacids when consumed with other acidic drugs
might lead to absorption of both the drugs resulting in reduced efficiency of
both the drugs.
Mouth-melting antacid is an emerging
trend in the antacid market. Antacids were available in tablet, liquid and
powder form until now, however, researchers have now come up with mouth-melting
antacids which are made up of micro mouth melting granules that easily melt in
the mouth. These granules present in the antacids act in the form of
effervescent. An example of a mouth melting instant relief antacid is
Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents
present in it with the contemporary mouth melting technology.
The manufacturers of antacids in the
USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by
the FDA. According to these regulations, an over-the-counter (OTC) antacid
product in a form suitable for oral administration is recognized safe and
effective only if it meets the conditions related to active ingredients
established by the regulatory body.
In March 2018, GlaxoSmithKline (GSK)
acquired Novartis for $13 billion. This acquisition would help GSK's
shareholder to seize the full worth of Novartis' consumer healthcare business.
Also, it would help GSK expand its pharmaceutical portfolio. Novartis is a
pharmaceutical firm manufacturing innovative drugs. It was founded in 1996 and
is headquartered in Basel, Switzerland.
Major players in the market are
GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd and
AstraZeneca PLC.
FOR MORE DETAILS https://www.wiseguyreports.com/reports/4588875-antacids-global-market-report-2020-including-1-drug
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and governments
around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment